Mitoxantrone in the treatment of multiple sclerosis: a single-center experience

Mitoxantrone in the treatment of multiple sclerosis: a single-center experience

OBJECTIVE: To investigate the secondary progressive multiple sclerosis (SPMS) patients treated with mitoxantrone (MIT) and discuss the effectiveness and side effects of MIT. METHODS: We retrospectively investigated 48 SPMS patients who completed or were still receiving MIT treatment. Expanded Disab...

Full description

Bibliographic Details
Main Authors: Özlem Taşkapılıoğlu, Deniz Kamacı Şener, Aslı Bahar Turan, Şükran Yurtoğulları, Ahmet Tütüncü, Sümeyye Güllülü, Gökhan Ocakoğlu, Ömer Faruk Turan
Format: Article
Language:English
Published: Galenos Yayinevi 2012-06-01
Series:Türk Nöroloji Dergisi
Subjects:
Multiple sclerosis
secondary progressive multiple sclerosis
immunosuppressive agents
immunomodulators
mitoxantrone
Online Access:http://www.tjn.org.tr/jvi.aspx?pdir=tjn&plng=eng&un=TJN-38039

Internet

http://www.tjn.org.tr/jvi.aspx?pdir=tjn&plng=eng&un=TJN-38039

Similar Items